| $164M | ||
| $143M | ||
| $143M | ||
| $76M | ||
| $60M | ||
| $57M |
Buys | $ | – | |
Sells | $ | – |
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Over the last 12 months, insiders at Enfusion, Inc. have bought $undefined and sold $undefined worth of Enfusion, Inc. stock.
On average, over the past 5 years, insiders at Enfusion, Inc. have bought $85.79M and sold $44.2M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,523,188 shares for transaction amount of $42.89M was made by Luo Roy (director) on 2021‑10‑25.
| Increased Positions | 0 | 0% | 0 | 0% |
| Decreased Positions | 0 | 0% | 0 | 0% |
| New Positions | 0 | New | 0 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 0 | 0% | 0 | 0% |